Mirum Pharmaceuticals, Inc.
MIRM
Revenue
77.88M
▲8.65M▲12.50%
3 Months ChangeAssets
660.75M
▲8.79M▲1.35%
3 Months ChangeLiabilities
431.77M
▲14.41M▲3.45%
3 Months ChangeFree Cash Flow
15.20M
▲34.01M▲180.78%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0001759425-24-000031
2024-08-07
Form 8-K
ID: 0001759425-24-000029
2024-06-17
Form 8-K
ID: 0001193125-24-162056
2024-06-06
Form 8-K
ID: 0001759425-24-000023
2024-05-31
Form 8-K
ID: 0001193125-24-151965
2024-05-08
Form 10-Q
ID: 0001759425-24-000019
2024-05-08
Form 8-K
ID: 0001759425-24-000017
2024-02-28
Form 8-K
ID: 0001759425-24-000005
2024-01-16
Form 8-K
ID: 0001193125-24-008569
2024-01-08
Form 8-K
ID: 0001193125-24-003965